Keywords: انسولین degludec; Insulin degludec; Insulin glargine; Type 2 diabetes; Blood glucose variability; Quality of life;
مقالات ISI انسولین degludec (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: انسولین degludec; 1,5-AG; 1,5-anhydroglucitol; AUC; area under curve; CGM; Continuous Glucose Monitoring; CI; confidence interval; CONGAn; Continuous Overlapping Net Glycemic Action; CV; Coefficient of Variance; DCCT; Diabetes Control and Complication Trial; FPG; fasting p
Keywords: انسولین degludec; Clinical trial; Continuous glucose monitoring; Basal-bolus insulin therapy; Insulin degludec; Insulin glargine; Type 1 diabetes
Keywords: انسولین degludec; Insulin; Glargine U-300; Insulin degludec; Basaglar; Lispro U-200; Afrezza; Regular U-500; Insulin therapy;
Keywords: انسولین degludec; Diabetes mellitus; Insulina basal; Análogo de insulina; Insulina degludec; Insulina glarginaDiabetes mellitus; Basal insulin; Insulin analogue; Insulin degludec; Insulin glargine
Morning administration of 0.4Â U/kg/day insulin glargine 300Â U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100Â U/mL in type 1 diabetes
Keywords: انسولین degludec; Insulin degludec; Insulin glargine; Pharmacodynamic; Pharmacokinetic; Type 1 diabetes; GIR-AUC0-24; area under the GIR over time curve; GIR-smFL0-24; fluctuation of the smoothed glucose infusion rate; LOESS; locally weighted regression in smoothing sc
Comparison of the pharmacodynamics of protamine zinc insulin and insulin degludec and validation of the continuous glucose monitoring system iPro2 in healthy cats
Keywords: انسولین degludec; Protamine zinc insulin; Insulin degludec; iPro2; Sof-sensor; Enlite-sensor; Continuous glucose monitoring system; CGMS; continuous glucose monitoring system; DM; diabetes mellitus; ISO; international organization for standardization; PBGM; portable blood
Expanded Basal Insulin Options for Type 2 Diabetes Mellitus
Keywords: انسولین degludec; basal insulin; concentrated insulin; insulin degludec; insulin glargine; U-500 insulin;
Real-life experience of patients starting insulin degludec. A multicenter analysis of 1064 subjects from the German/Austrian DPV registry
Keywords: انسولین degludec; Insulin degludec; Type 1 diabetes; Type 2 diabetes; Real-world data;
A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus
Keywords: انسولین degludec; glargine; insulin degludec; type 1 diabetes mellitus; type 2 diabetes mellitus;
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study
Keywords: انسولین degludec; Basal-bolus therapy; Type 1 diabetes; Insulin degludec; Glycaemic control;
New insulin types in type 1 diabetes mellitus
Keywords: انسولین degludec; Diabetes mellitus; Basal insulin; Insulin analogue; Insulin degludec; Insulin glargineDiabetes mellitus; Insulina basal; Análogo de insulina; Insulina degludec; Insulina glargina
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials
Keywords: انسولین degludec; Meta-analysis; Diabetes; Hypoglycaemia; Insulin therapy; Fasting plasma glucose; ANCOVA; analysis of covariance; CI; confidence interval; FPG; fasting plasma glucose; IDeg; insulin degludec; IDet; insulin detemir; IGlar; insulin glargine; LOCF; last obser
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial
Keywords: انسولین degludec; Insulin degludec; Insulin aspart; Type 2 diabetes; HbA1c;
Clinical use of insulin degludec
Keywords: انسولین degludec; Clinical practice; Diabetes; Insulin; Insulin degludec; Hypoglycaemia; Dosing;
Efficacité et tolérance de l'insuline dégludec dans le diabète de type 1 et de type 2 : résultats des essais cliniques de phase IIIa
Keywords: انسولین degludec; Insuline dégludec; insuline basale; hypoglycémie; flexibilité; hypoglycémie nocturne; Insulin degludec; basal insulin; hypoglycemia; flexibility; nocturnal hypoglycemia;
Insuline dégludec : mode d'action et profil pharmacocinétique
Keywords: انسولین degludec; Insuline dégludec; action prolongée; multi-hexamères solubles; Insulin degludec; ultra-long acting insulin; soluble multihexamers;
Nueva insulina basal de acción ultralenta: insulina degludec
Keywords: انسولین degludec; Análogos de la insulina; Insulina degludec; Hipoglucemia; Diabetes mellitus tipo 1; Diabetes mellitus tipo 2; Insulin analogue; Insulin degludec; Hypoglycaemia; Type 1 diabetes mellitus; Type 2 diabetes mellitus;